Malaysia Biosimilars Market (2024-2030) Outlook | Value, Industry, Companies, Growth, Analysis, Trends, Revenue, Size, Share & Forecast

Market Forecast By Product (Insulin, Follitropin, Calcitonin, Glucagon, Teriparatide, Others), By Indication (Oncology, Offsite Treatment, Chronic Disorders, Blood Disorders, Infectious Diseases, Others), By Manufacturing (Outsourced, In-house) And Competitive Landscape
Product Code: ETC069945 Publication Date: Jun 2023 Updated Date: Jan 2024 Product Type: Report
Publisher: 6Wresearch No. of Pages: 70 No. of Figures: 35 No. of Tables: 5

Malaysia Biosimilars Market Synopsis

The Malaysia biosimilars market is expected to grow at a CAGR of 16.9% from 2021-2027. The growing prevalence of chronic diseases such as diabetes, cancer, rheumatoid arthritis and anemia has driven the demand for low cost biologics drugs which are driving the growth of the Malaysia biosimilars market over the forecast period. Additionally, increased government support in terms of access to healthcare financing options coupled with initiatives taken by local drug manufacturers have also further spurred market growth. Furthermore, supportive regulations promoting adoption and uptake of biosimilar medicines will continue to drive market expansion over the forecast period

Key Highlights of the Report:

  • Malaysia Biosimilars Market Outlook
  • Market Size of Malaysia Biosimilars Market, 2020
  • Forecast of Malaysia Biosimilars Market, 2027
  • Historical Data and Forecast of Malaysia Biosimilars Revenues & Volume for the Period 2023 - 2027
  • Malaysia Biosimilars Market Trend Evolution
  • Malaysia Biosimilars Market Drivers and Challenges
  • Malaysia Biosimilars Price Trends
  • Malaysia Biosimilars Porter's Five Forces
  • Malaysia Biosimilars Industry Life Cycle
  • Historical Data and Forecast of Malaysia Biosimilars Market Revenues & Volume By Product for the Period 2023 - 2027
  • Historical Data and Forecast of Malaysia Biosimilars Market Revenues & Volume By Insulin for the Period 2023 - 2027
  • Historical Data and Forecast of Malaysia Biosimilars Market Revenues & Volume By Follitropin for the Period 2023 - 2027
  • Historical Data and Forecast of Malaysia Biosimilars Market Revenues & Volume By Calcitonin for the Period 2023 - 2027
  • Historical Data and Forecast of Malaysia Biosimilars Market Revenues & Volume By Glucagon for the Period 2023 - 2027
  • Historical Data and Forecast of Malaysia Biosimilars Market Revenues & Volume By Teriparatide for the Period 2023 - 2027
  • Historical Data and Forecast of Malaysia Biosimilars Market Revenues & Volume By Others for the Period 2023 - 2027
  • Historical Data and Forecast of Malaysia Biosimilars Market Revenues & Volume By Indication for the Period 2023 - 2027
  • Historical Data and Forecast of Malaysia Biosimilars Market Revenues & Volume By Oncology for the Period 2023 - 2027
  • Historical Data and Forecast of Malaysia Biosimilars Market Revenues & Volume By Offsite Treatment for the Period 2023 - 2027
  • Historical Data and Forecast of Malaysia Biosimilars Market Revenues & Volume By Chronic Disorders for the Period 2023 - 2027
  • Historical Data and Forecast of Malaysia Biosimilars Market Revenues & Volume By Blood Disorders for the Period 2023 - 2027
  • Historical Data and Forecast of Malaysia Biosimilars Market Revenues & Volume By Infectious Diseases for the Period 2023 - 2027
  • Historical Data and Forecast of Malaysia Biosimilars Market Revenues & Volume By Others for the Period 2023 - 2027
  • Historical Data and Forecast of Malaysia Biosimilars Market Revenues & Volume By Manufacturing for the Period 2023 - 2027
  • Historical Data and Forecast of Malaysia Biosimilars Market Revenues & Volume By Outsourced for the Period 2023 - 2027
  • Historical Data and Forecast of Malaysia Biosimilars Market Revenues & Volume By In-house for the Period 2023 - 2027
  • Malaysia Biosimilars Import Export Trade Statistics
  • Market Opportunity Assessment By Product
  • Market Opportunity Assessment By Indication
  • Market Opportunity Assessment By Manufacturing
  • Malaysia Biosimilars Top Companies Market Share
  • Malaysia Biosimilars Competitive Benchmarking By Technical and Operational Parameters
  • Malaysia Biosimilars Company Profiles
  • Malaysia Biosimilars Key Strategic Recommendations
Frequently Asked Questions About the Market Study (FAQs):
6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 Malaysia Biosimilars Market Overview

3.1 Malaysia Country Macro Economic Indicators

3.2 Malaysia Biosimilars Market Revenues & Volume, 2020 & 2027F

3.3 Malaysia Biosimilars Market - Industry Life Cycle

3.4 Malaysia Biosimilars Market - Porter's Five Forces

3.5 Malaysia Biosimilars Market Revenues & Volume Share, By Product, 2020 & 2027F

3.6 Malaysia Biosimilars Market Revenues & Volume Share, By Indication, 2020 & 2027F

3.7 Malaysia Biosimilars Market Revenues & Volume Share, By Manufacturing, 2020 & 2027F

4 Malaysia Biosimilars Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.3 Market Restraints

5 Malaysia Biosimilars Market Trends

6 Malaysia Biosimilars Market, By Types

6.1 Malaysia Biosimilars Market, By Product

6.1.1 Overview and Analysis

6.1.2 Malaysia Biosimilars Market Revenues & Volume, By Product, 2018 - 2027F

6.1.3 Malaysia Biosimilars Market Revenues & Volume, By Insulin, 2018 - 2027F

6.1.4 Malaysia Biosimilars Market Revenues & Volume, By Follitropin, 2018 - 2027F

6.1.5 Malaysia Biosimilars Market Revenues & Volume, By Calcitonin, 2018 - 2027F

6.1.6 Malaysia Biosimilars Market Revenues & Volume, By Glucagon, 2018 - 2027F

6.1.7 Malaysia Biosimilars Market Revenues & Volume, By Teriparatide, 2018 - 2027F

6.1.8 Malaysia Biosimilars Market Revenues & Volume, By Others, 2018 - 2027F

6.2 Malaysia Biosimilars Market, By Indication

6.2.1 Overview and Analysis

6.2.2 Malaysia Biosimilars Market Revenues & Volume, By Oncology, 2018 - 2027F

6.2.3 Malaysia Biosimilars Market Revenues & Volume, By Offsite Treatment, 2018 - 2027F

6.2.4 Malaysia Biosimilars Market Revenues & Volume, By Chronic Disorders, 2018 - 2027F

6.2.5 Malaysia Biosimilars Market Revenues & Volume, By Blood Disorders, 2018 - 2027F

6.2.6 Malaysia Biosimilars Market Revenues & Volume, By Infectious Diseases, 2018 - 2027F

6.2.7 Malaysia Biosimilars Market Revenues & Volume, By Others, 2018 - 2027F

6.3 Malaysia Biosimilars Market, By Manufacturing

6.3.1 Overview and Analysis

6.3.2 Malaysia Biosimilars Market Revenues & Volume, By Outsourced, 2018 - 2027F

6.3.3 Malaysia Biosimilars Market Revenues & Volume, By In-house, 2018 - 2027F

7 Malaysia Biosimilars Market Import-Export Trade Statistics

7.1 Malaysia Biosimilars Market Export to Major Countries

7.2 Malaysia Biosimilars Market Imports from Major Countries

8 Malaysia Biosimilars Market Key Performance Indicators

9 Malaysia Biosimilars Market - Opportunity Assessment

9.1 Malaysia Biosimilars Market Opportunity Assessment, By Product, 2020 & 2027F

9.2 Malaysia Biosimilars Market Opportunity Assessment, By Indication, 2020 & 2027F

9.3 Malaysia Biosimilars Market Opportunity Assessment, By Manufacturing, 2020 & 2027F

10 Malaysia Biosimilars Market - Competitive Landscape

10.1 Malaysia Biosimilars Market Revenue Share, By Companies, 2020

10.2 Malaysia Biosimilars Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Related Reports

Industry Events and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All